Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System
about
Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Assessing the Association Betw ...... Adverse Event Reporting System
@en
type
label
Assessing the Association Betw ...... Adverse Event Reporting System
@en
prefLabel
Assessing the Association Betw ...... Adverse Event Reporting System
@en
P2093
P50
P356
P1433
P1476
Assessing the Association Betw ...... Adverse Event Reporting System
@en
P2093
Emily W Gower
John B Buse
Wenchao Lu
P304
P356
10.2337/DC18-1893
P577
2018-12-07T00:00:00Z